U. Griese

EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival.

G. Ott, M. Faehling, S. Kuom, 2013, Lung cancer.

Evolutionary pharmacogenetics of CYP2D6 in Ngawbe Guaymi of Panama: allele-specific PCR detection of the CYP2D6B allele and RFLP analysis.

M. Eichelbaum, T. D. Arias, L. Jorge, 1993, Pharmacogenetics (London).

EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: a case-control study of overall survival.

G. Ott, M. Faehling, S. Kuom, 2013, Lung cancer.